UNITED STA TES p A TENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www .uspto.gov
`
`APPLICATION NO.
`
`121787,283
`
`ISSUE DATE
`
`04/30/2013
`
`PATENT NO.
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`8431549
`
`30015730-0053
`
`4251
`
`7590
`26263
`DENTONS US LLP
`P.O. BOX 061080
`CHICAGO, IL 60606-1080
`
`04/10/2013
`
`The projected patent number and issue date are specified above.
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 47 day(s). Any patent to issue from the above-identified application will
`include an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEB site (http://pair.uspto.gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the
`Office of Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee
`payments should be directed to the Application Assistance Unit (AAU) of the Office of Data Management
`(ODM) at (571)-272-4200.
`
`APPLICANT(s) (Please see PAIR WEB site http://pair.uspto.gov for additional applicants):
`
`Mary Jane Helenek, Brookville, NY;
`Marc L. Tokars, Douglassville, PA;
`Richard P. Lawrence, Southold, NY;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit SelectUSA.gov.
`
`IR103 (Rev. 10/09)
`
`Pharmacosmos, Exh. 1006, p. 1
`
`

`

`l\fa.U Stn·p ISSUE FEE
`Ctm.1mi&'iiom\r for Pi~t~ntii
`PJ\ nox 14,·W
`Ak~~nirlrfa, Vkgfol~ 223t~-14..~}
`{S1lf-·273--2AA5
`
`SNH DENTON l!S LLP
`F.O. HOX 06l0~0
`ClllCAGO, lL 600:.if~·WSO
`
`'"""""""'"""'""'""""""!'""""""""'"""""'""'""]
`""""
`A~~:r 'i)N'f't
`EX.~\;-...f:}Jf::R
`~
`,.. .......................................... --.:.. .................................... ~™ t
`
`[
`
`.,
`,.,; ..
`
`3 ..
`
`<!<:. ~;;;,_~;:~!<;\:::llc i<'d"} "-tl' ~;ib_:_:,(,<t"<.i:
`Q P;.::hli:..::.Hi:);.~ .h:'~': ~N•.) 8H~;.:.;i :::·:~H~Y dh~-<:-~~~1i .r~~~;.'!~~-~i,':d}
`0 -"'b:;.:_:,·;: ()d;::-, ii <>f {'r:pk:;
`................................ .
`
`·'kl .:~'.<>ym<·;g •.>!T"''(,j: (.Pk~•~ fir::.t nmi~!y ;m;; 1>~'Yk>\1:>!y P\>id i;;$\W fr<' •ilmn.\ ai.><M')
`:~ .. '\ (.h~x~.k ;~ t~fH~k:-s~~~.
`[ill P~~y~n~':.::~;. by :..~f~X'Ht :..~:»d::~~~~~~-:P.'~~:.~~.>$~~*~)t~x ':FL:-s
`J:~·;s-~~ ~ ... ·~::~l:,~,
`----- """"""""""' .............................. __ .............. ::... .................... -.;.. ...................................... -.:-:
`w :;~,;.;;:,~;~;~~\;; _1~,;·g;;~;~~\''.~~:~~:;;; ~','.;~r;;y. 1~Ct'.\;'{;;'~\ ~~'<'~g;,~:'.L'~;:i~~;~~<.~,~'.'.;,';}~\~\ :1\~m; 1.
`...................................... , ...................... ,,, ............ , .... ...,.....................................
`
`.
`
`~~~~~~~i1iE~~l~~~~~~~~~~\"1~~l~~~~~§f
`
`~.:·~):·for ~~s-:~ V=~;::::~e.."-:·~::::·.k .K'.~~~nrhr~n Ad of .t ~~~)$~ ~~:· f~:f~:(>"!":$. .=~N: g-::-;;:.~.:,i:.~~'~ t;.~ rf~$f'\.QK~ ~J) ;s ~-:·~~k:~th"~:-: ~~,<( i~~:t~-;.fH~~~-k-:~l tlnk~:~$ it di~pl~y::; ~ ,.~~ud O~H~ f.nntr·d. mJ~r .. t~~r.
`
`~"""'~~~~~~-~~~~~~~w>w»w»w»w»w»w»w»w».__,_,_,_,_,~~~""°""""~~~~~~~..,,.,M»M»M»M»M»M>)M»M»M~~~~~~~~~~"""'"'
`
`Pharmacosmos, Exh. 1006, p. 2
`
`

`

`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Applicant(s): Mary Jane Helenek et al.
`
`Confirmation No:
`
`4251
`
`Serial No:
`
`12/787,283
`
`Filed:
`
`25 May 2010
`
`Examiner:
`
`Jonathan S. Lau
`
`Art Unit:
`
`1623
`
`Customer No:
`
`26263
`
`Docket No: 30015730-0053
`
`Title:
`
`METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
`
`FILED VIA EFS WEB
`MAIL STOP ISSUE FEE
`Commission for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`NOTIFICATION OF LOSS OF ENTITLEMENT TO SMALL ENTITY STATUS
`
`Dear Sir:
`
`In accordance with 37 C.F.R. 1.27(g)(2), Applicants hereby notify the U.S. Patent
`
`and Trademark Office that they are no longer eligible to claim Small Entity Status in the
`
`above referenced application.
`
`It is believed that no fees are due with filing this Notification. However, the
`
`Commissioner is herby authorized to charge any fees that may be required or credit any
`
`overpayments to SNR Denton US LLP Deposit Account No. 19-3140.
`
`20 March 2013
`Date
`
`Respectfully Submitted,
`
`/Kathleen E. Chaffee/
`Kathleen E. Chaffee, Reg. No. 69,903
`Agent for Applicant(s)
`
`SNR Denton US LLP
`P.O. Box 061080
`Wacker Drive Station, Willis Tower
`Chicago, IL 60606-1080
`Phone: 973-912-7174
`Fax: 973-912-7199
`
`1 of 1
`
`Pharmacosmos, Exh. 1006, p. 3
`
`

`

`Electronic Patent Application Fee Transmittal
`
`Application Number:
`
`Filing Date:
`
`12787283
`
`25-May-2010
`
`Title of Invention:
`
`METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
`
`First Named Inventor/Applicant Name:
`
`Mary Jane Helenek
`
`Filer:
`
`Kathleen E. Chaffee/Drenda Nemeth
`
`Attorney Docket Number:
`
`30015730-0053
`
`Filed as Large Entity
`
`Utility under 35 USC 111 (a) Filing Fees
`
`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total in
`USO($)
`
`Basic Filing:
`
`Pages:
`
`Claims:
`
`Miscellaneous-Filing:
`
`Petition:
`
`Patent-Appeals-and-Interference:
`
`Post-Allowance-and-Post-Issuance:
`
`Utility Appl Issue Fee
`
`Publ. Fee- Early, Voluntary, or Normal
`
`1501
`
`1504
`
`1
`
`1
`
`1780
`
`300
`
`1780
`
`300
`
`Pharmacosmos, Exh. 1006, p. 4
`
`

`

`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total in
`USO($)
`
`Extension-of-Time:
`
`Miscellaneous:
`
`Total in USO($)
`
`2080
`
`Pharmacosmos, Exh. 1006, p. 5
`
`

`

`Electronic Acknowledgement Receipt
`
`EFSID:
`
`Application Number:
`
`15305812
`
`12787283
`
`International Application Number:
`
`Confirmation Number:
`
`4251
`
`Title of Invention:
`
`METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
`
`First Named Inventor/Applicant Name:
`
`Mary Jane Helenek
`
`Customer Number:
`
`26263
`
`Filer:
`
`Kathleen E. Chaffee/Drenda Nemeth
`
`Filer Authorized By:
`
`Kathleen E. Chaffee
`
`Attorney Docket Number:
`
`30015730-0053
`
`Receipt Date:
`
`Filing Date:
`
`Time Stamp:
`
`20-MAR-2013
`
`25-MAY-2010
`
`11:28:28
`
`Application Type:
`
`Utility under 35 USC 111 (a)
`
`Payment information:
`
`Submitted with Payment
`
`Payment Type
`
`Payment was successfully received in RAM
`
`RAM confirmation Number
`
`yes
`
`Credit Card
`
`$2080
`
`30493
`
`Deposit Account
`
`Authorized User
`
`File Listing:
`Document I
`Number
`
`Document Description
`
`File Name
`
`I
`
`File Size( Bytes)/ I Multi I Pages
`(if appl.)
`Message Digest
`Part /.zip
`
`I
`
`Pharmacosmos, Exh. 1006, p. 6
`
`

`

`1
`
`Issue Fee Payment (PT0-85B)
`
`I ss u e_fee_ trans m itta I_ co rrecti n
`g_small_entity _status_execute
`d.pdf
`
`1822305
`
`95d9ee8f462988373a1191 e5e3223608715
`5768f
`
`no
`
`1
`
`Warnings:
`
`Information:
`
`2
`
`Notification of loss of entitlement to
`small entity status
`
`Notification_Of_Loss_Of_Entitl
`ement_ To_Small_Entity_Status
`_20_March_2013.pdf
`
`58748
`
`030a2974be5387bdd 1 bf5ef1 2c71 b07d388
`fc132
`
`no
`
`1
`
`Warnings:
`
`Information:
`
`3
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`no
`
`2
`
`31760
`
`62142d 1 baa823cf9f50bf317 es b814 3 5b4ea
`6495
`
`Warnings:
`
`Information:
`
`Total Files Size (in bytes)
`
`1912813
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New A~~lications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International A~~lication under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/E0/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International A~~lication Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 181 O), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/R0/1 OS) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`Pharmacosmos, Exh. 1006, p. 7
`
`

`

`PTO/SB/14 (07-07)
`Approved for use through 06/30/2010. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`SUPPLEMENTARY
`Application Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`30015730-0053
`
`Application Number
`
`Title of Invention
`
`METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`I QParty of Interest under 35 U.S.C. 118
`
`Secrecy Order 37 CFR 5.2
`D Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`r
`r
`,pp 1can t I f
`n orma ion:
`A
`APPiicant 1
`Applicant Authority @Inventor I QLegal Representative under 35 U.S.C. 117
`Prefix Given Name
`Middle Name
`
`Family Name
`
`Suffix
`
`Mary
`Jane
`Residence Information (Select One) @ US Residency
`City
`State/Provi nee
`us
`
`Brookville
`
`Citizenship under 37 CFR 1.41(b) i
`Mailing Address of Applicant:
`Address 1
`
`13 Evans Drive
`
`Helenek
`0 Non US Residency 0 Active US Military Service
`I Country of Residence i I us
`I NY
`
`Address 2
`
`City
`
`I Brookville
`Postal Code
`
`11545
`
`I State/Province
`I Countryi I us
`
`I NY
`
`APPiicant 2
`Applicant Authority @Inventor I QLegal Representative under 35 U.S.C. 117
`Prefix Given Name
`Middle Name
`
`I QParty of Interest under 35 U.S.C. 118
`
`Family Name
`
`Suffix
`
`Marc
`L.
`Residence Information (Select One) @ US Residency
`City
`State/Provi nee
`us
`
`Douglassville
`
`Citizenship under 37 CFR 1.41(b) i
`Mailing Address of Applicant:
`Address 1
`
`202 Farmingdale Drive
`
`Tokars
`0 Non US Residency 0 Active US Military Service
`I Country of Residence i I us
`I PA
`
`Address 2
`
`City
`
`I Douglassville
`Postal Code
`
`19618
`
`I State/Province
`I Countryi I us
`
`I PA
`
`Applicant 3
`Applicant Authority @Inventor I QLegal Representative under 35 U.S.C. 117
`Prefix Given Name
`Middle Name
`
`I QParty of Interest under 35 U.S.C. 118
`
`Family Name
`
`Suffix
`
`Richard
`P.
`Residence Information (Select One) @ US Residency
`City
`State/Provi nee
`-New-¥-efk.-_Calve rto 11_
`
`Lawrence
`0 Non US Residency 0 Active US Military Service
`I Country of Residence i I us
`I NY
`
`EFS Web 2.2.2
`
`Pharmacosmos, Exh. 1006, p. 8
`
`

`

`PTO/SB/14 (07-07)
`Approved for use through 06/30/2010. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`30015730-0053
`
`Application Number
`
`Title of Invention
`
`METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
`
`Citizenship under 37 CFR 1.41(b) i
`Mailing Address of Applicant:
`Address 1
`
`94 Young Avenue
`
`I us
`
`City
`
`Address 2
`I State/Province
`I Calverton
`I Countryi I us
`Postal Code
`11933
`All Inventors Must Be Listed - Additional Inventor Information blocks may be
`generated within this form by selecting the Add button.
`
`I NY
`
`I? AiiQ
`
`JI
`
`Correspondence Information:
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`D An Address is being provided for the correspondence Information of this application.
`Customer Number
`
`26263
`
`Email Address
`
`patents@sonnenschein.com
`
`Application Information:
`
`Title of the Invention
`
`METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
`I Small Entity Status Claimed
`
`~
`
`Attorney Docket Number 30015730-0053
`
`Application Type
`
`Non provisional
`
`Subject Matter
`
`Utility
`
`Suggested Class (if any)
`
`Suggested Technology Center (if any)
`
`I Sub Class (if any)I
`I Suggested Figure for Publication (if any) I
`
`2
`
`Total Number of Drawing Sheets (if any)
`Publication Information:
`D Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`Request Not to Publish. I hereby request that the attached application not be published under 35 U.S.
`D C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the subject of
`an application filed in another country, or under a multilateral international agreement, that requires publication at
`eighteen months after filing.
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Enter
`either Customer Number
`or
`complete
`the Representative Name
`section
`below.
`If
`both
`are completed the Customer Number will be used for the Representative Information during processing.
`
`sections
`
`Please Select One:
`
`I (!) Customer Number
`
`I 0 US Patent Practitioner
`
`I 0 Limited Recognition (37 CFR 11.9)
`
`EFS Web 2.2.2
`
`Pharmacosmos, Exh. 1006, p. 9
`
`

`

`PTO/SB/14 (07-07)
`Approved for use through 06/30/2010. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`30015730-0053
`
`Application Number
`
`Title of Invention
`
`METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
`
`I Customer Number
`
`I 26263
`
`Prior Application Status Pending
`
`Domestic BenefiUNational Stage Information:
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 365( c) or indicate National Stage
`entry from a PCT application. Providing this information in the application data sheet constitutes the specific reference required by
`35 U.S.C. 119(e) or 120, and 37 CFR 1.78(a)(2) or CFR 1.78(a)(4), and need not otherwise be made part of the specification.
`I B.~ffifuWMI
`Filing Date (YYYY-MM-DD)
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Prior Application Status Expired
`
`Continuation of
`
`11620986
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`2007-01-08
`I R~ffii@WI
`Filing Date (YYYY-MM-DD)
`
`11620986
`
`non provisional of
`
`60757119
`
`2006-01-06
`
`Additional Domestic BenefiUNational Stage Data may be generated within this form
`by selecting the Add button.
`
`Foreign Priority Information:
`This section allows for the applicant to claim benefit of foreign priority and to identify any prior foreign application for which priority is
`not claimed. Providing this information in the application data sheet constitutes the claim for priority as required by 35 U.S.C. 119(b)
`and 37 CFR 1.55(a).
`
`Application Number
`
`Country i
`
`IR~m9~WI
`Parent Filing Date (YYYY-MM-DD)
`Priority Claimed
`(!) Yes 0 No
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`Assignee Information:
`Providing this information in the application data sheet does not substitute for compliance with any requirement of part 3 of Title 37
`of the CFR to have an assignment recorded in the Office.
`
`Assignee 1
`If the Assignee is an Organization check here.
`
`~
`
`Organization Name
`
`I Luitpold Pharmaceuticals, Inc.
`Mailing Address Information:
`
`Address 1
`
`Address 2
`
`City
`
`Country ii us
`
`Phone Number
`
`Email Address
`
`One Luitpold Drive
`
`Shirley
`
`State/Provi nee
`
`NY
`
`Postal Code
`
`Fax Number
`
`11967
`
`Additional Assignee Data may be generated within this form by selecting the Add
`button.
`
`EFS Web 2.2.2
`
`Pharmacosmos, Exh. 1006, p. 10
`
`

`

`PTO/SB/14 (07-07)
`Approved for use through 06/30/2010. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1. 76
`
`Attorney Docket Number
`
`30015730-0053
`
`Application Number
`
`Title of Invention
`
`METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
`
`Signature:
`A signature of the applicant or representative is required in accordance with 37 CFR 1.33 and 10.18. Please see 37
`CFR 1.4(d) for the form of the signature.
`
`Signature
`
`/Kathleen E. Chaffee/
`
`First Name
`
`Kathleen E.
`
`Last Name
`
`I Chaffee
`
`I
`
`Date (YYYY-MM-DD) 2013-03-19
`
`Registration Number
`
`69903
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.2
`
`Pharmacosmos, Exh. 1006, p. 11
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent. If you do not
`furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom of Information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee,
`during an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuant
`to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`9.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`US PTO becomes aware of a violation or potential violation of law or regulation.
`
`EFS Web 2.2.2
`
`Pharmacosmos, Exh. 1006, p. 12
`
`

`

`Electronic Acknowledgement Receipt
`
`EFSID:
`
`Application Number:
`
`15299849
`
`12787283
`
`International Application Number:
`
`Confirmation Number:
`
`4251
`
`Title of Invention:
`
`METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
`
`First Named Inventor/Applicant Name:
`
`Mary Jane Helenek
`
`Customer Number:
`
`26263
`
`Filer:
`
`Kathleen E. Chaffee
`
`Filer Authorized By:
`
`Attorney Docket Number:
`
`30015730-0053
`
`Receipt Date:
`
`Filing Date:
`
`Time Stamp:
`
`19-MAR-2013
`
`25-MAY-2010
`
`16:04:56
`
`Application Type:
`
`Utility under 35 USC 111 (a)
`
`Payment information:
`
`Submitted with Payment
`
`I no
`
`File Listing:
`
`Document
`Number
`
`Document Description
`
`File Name
`
`File Size( Bytes)/
`Message Digest
`
`Multi
`Part /.zip
`
`Pages
`(if appl.)
`
`1
`
`Application Data Sheet
`
`Supp_ADS_30015730-0053_us
`pto.pdf
`
`567466
`
`3ef4 73014 76b05f56ef25c61 fcl 53fe833c00
`e14
`
`no
`
`5
`
`Warnings:
`
`Information:
`
`Pharmacosmos, Exh. 1006, p. 13
`
`

`

`This is not an USPTO supplied ADS fillable form
`
`Total Files Size (in bytes)~
`
`567466
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/E0/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 181 O), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/R0/1 OS) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`Pharmacosmos, Exh. 1006, p. 14
`
`

`

`UNITED STA IBS p A IBNT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`NOTICE OF ALLOWANCE AND FEE(S) DUE
`
`26263
`7590
`SNR DENTON US LLP
`P.O. BOX 061080
`CHICAGO, IL 60606-1080
`
`02/28/2013
`
`EXAMINER
`
`LAU, JONATHAN S
`
`ART UNIT
`
`PAPER NUMBER
`
`1623
`
`DATE MAILED: 02/28/2013
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`121787,283
`
`05/25/2010
`
`Mary Jane Helenek
`
`30015730-0053
`
`4251
`
`TITLE OF INVENTION: METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
`
`APPLN. TYPE
`
`SMALL ENTITY
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATEDUE
`
`nonprovisional
`
`YES
`
`$885
`
`$300
`
`$0
`
`$1185
`
`05/28/2013
`
`THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT.
`PROSECUTION ON THE MERITS IS CLOSED. THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS.
`THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON
`PETITION BY THE APPLICANT. SEE 37 CFR 1.313 AND MPEP 1308.
`
`THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAID WITHIN THREE MONTHS FROM THE
`MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED. THIS
`STATUTORY PERIOD CANNOT BE EXTENDED. SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES
`IF AN ISSUE FEE HAS
`NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION.
`PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM
`WILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW
`DUE.
`
`HOW TO REPLY TO THIS NOTICE:
`
`I. Review the SMALL ENTITY status shown above.
`
`If the SMALL ENTITY is shown as YES, verify your current
`SMALL ENTITY status:
`
`A. If the status is the same, pay the TOTAL FEE(S) DUE shown
`above.
`B. If the status above is to be removed, check box Sb on Part B -
`Fee(s) Transmittal and pay the PUBLICATION FEE (if required)
`and twice the amount of the ISSUE FEE shown above, or
`
`If the SMALL ENTITY is shown as NO:
`
`A. Pay TOTAL FEE(S) DUE shown above, or
`
`B. If applicant claimed SMALL ENTITY status before, or is now
`claiming SMALL ENTITY status, check box Sa on Part B - Fee(s)
`Transmittal and pay the PUBLICATION FEE (if required) and 1/2
`the ISSUE FEE shown above.
`
`IL PART B - FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office
`(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required). If you are charging the fee(s) to your deposit account, section "4b"
`of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted. If an equivalent of Part B is filed, a
`request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing
`the paper as an equivalent of Part B.
`
`III. All communications regarding this application must give the application number. Please direct all communications prior to issuance to
`Mail Stop ISSUE FEE unless advised to the contrary.
`
`IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of
`maintenance fees. It is patentee's responsibility to ensure timely payment of maintenance fees when due.
`
`PTOL-85 (Rev. 02/11)
`
`Page 1of3
`
`Pharmacosmos, Exh. 1006, p. 15
`
`

`

`PART B - FEE(S) TRANSMITTAL
`
`Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`(571)-273-2885
`
`or Fax
`
`INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks 1 through 5 should be completed where
`appropriate. All further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current correspondence address as
`indicated unless corrected below or directed otherwise in Block 1, by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS" for
`maintenance fee notifications.
`CURRENT CORRESPONDENCE ADDRESS (Note: Use Block 1 for any change of address)
`
`26263
`7590
`SNR DENTON US LLP
`P.O. BOX 061080
`CHICAGO, IL 60606-1080
`
`02/28/2013
`
`Note: A certificate of mailing can only be used for domestic mailings of the
`Fee(s) Transmittal. This certificate cannot be used for any other accompanying
`papers. Each additional paper, such as an assignment or formal drawing, must
`have its own certificate of mailing or transmission.
`
`Certificate of Mailing or Transmission
`I hereby certify that this Fee(s) Transmittal is being deposited with the United
`States Postal Service with sufficient postage for first class mail in an envelope
`addressed to the Mail Stop ISSUE FEE address above, or being facsimile
`transmitted to the USPTO (571) 273-2885, on the date indicated below.
`
`(Depositor's name)
`
`(Signature)
`
`(Date)
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`121787,283
`
`05/25/2010
`
`Mary Jane Helenek
`
`30015730-0053
`
`4251
`
`TITLE OF INVENTION: METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON
`
`APPLN. TYPE
`
`SMALL ENTITY
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATEDUE
`
`nonprovisional
`
`YES
`
`$885
`
`$300
`
`$0
`
`$1185
`
`05/28/2013
`
`EXAMINER
`
`ART UNIT
`
`CLASS-SUBCLASS
`
`LAU, JONATHAN S
`
`1623
`
`514-058000
`
`1. Change of correspondence address or indication of "Fee Address" (37
`CFR 1.363).
`0 Change of correspondence address (or Change of Correspondence
`Address form PTO/SB/122) attached.
`0 "Fee Address" indication (or "Fee Address" Indication form
`PTO/SB/47; Rev 03-02 or more recent) attached. Use of a Customer
`Number is required.
`
`2. For printing on the patent front page, list
`(1) the names of up to 3 registered patent attorneys
`or agents OR, alternatively,
`(2) the name of a single firm (having as a member a
`registered attorney or agent) and the names of up to
`2 registered patent attorneys or agents. If no name is
`listed, no name will be printed.
`
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`PLEASE NOTE: Unless an assignee is identified below, n